127 related articles for article (PubMed ID: 38267332)
1. Impact of innovative immunization strategy on PCV13 vaccination coverage among children under 5 years in Weifang city, China: A retrospective study.
Wang CP; Lin YT; Du YZ; Zhang T; Wang YY; Wang YJ; Wang JC; Xu RY; Wang ZS; Wang Y; Feng LZ
Vaccine; 2024 Feb; 42(5):1136-1144. PubMed ID: 38267332
[TBL] [Abstract][Full Text] [Related]
2. 13-Valent pneumococcal conjugate vaccines vaccination innovative strategy in Weifang City, China: a case study.
Wang J; Wang Y; Xu R; Zhang T; Jiang Y; Wang Y; Wang Y; Du Y; Sun W; Deng K; Yang W; Wang Z; Feng L; Wang C
Infect Dis Poverty; 2023 Dec; 12(1):110. PubMed ID: 38037092
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated with PCV13 Vaccine Hesitancy in Parents under an Innovative Immunization Strategy: a Cross-Sectional Study - Weifang City, Shandong Province, China, 2021.
Du Y; Wang Y; Zhang T; Ma L; Xie S; Wang Y; Yang Y; Li J; Feng Y; Wang Y; Qi W; Yang W; Zhou J; Wang C; Feng L
China CDC Wkly; 2023 Mar; 5(12):271-277. PubMed ID: 37138893
[TBL] [Abstract][Full Text] [Related]
4. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
[TBL] [Abstract][Full Text] [Related]
5. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
Nuorti JP; Whitney CG;
MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
[TBL] [Abstract][Full Text] [Related]
6. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
7. Invasive pneumococcal disease and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged ≤59 months---selected U.S. regions, 2010--2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(43):1477-81. PubMed ID: 22048728
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of 13-valent pneumococcal conjugate vaccine against vaccine-serotype community acquired pneumococcal diseases among children in China: A test-negative case-control study.
Xiaofei L; Yudan LI; Qinghui C; Jiaming S; Benfeng Z; Youyi Z; Biying W; Lijun Y; Jun Z; Jianmei T; Lin L; Xuejun S; Genming Z; Tao Z
Vaccine; 2024 Feb; 42(6):1275-1282. PubMed ID: 38296700
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of domestic 13-valent pneumococcal conjugate vaccine for children under 5 years of age in mainland China.
Wang C; Su L; Mu Q; Gu X; Guo X; Wang X
Hum Vaccin Immunother; 2021 Jul; 17(7):2241-2248. PubMed ID: 33577390
[No Abstract] [Full Text] [Related]
10. Willingness of Caregivers to Have Their Children Vaccinated with Pneumococcal Vaccines in the Context of an Innovative Immunization Strategy - Weifang City, Shandong Province, 2021.
Yang Y; Zhang T; Wang Y; Ma L; Xie S; Zhou J; Qi W; Wang Q; Dai P; Du Y; Feng L; Wang C; Yang W
China CDC Wkly; 2022 May; 4(20):421-425. PubMed ID: 35685692
[TBL] [Abstract][Full Text] [Related]
11. Low vaccination coverage of pneumococcal conjugate vaccines (PCVs) in Shanghai, China: A database analysis based on birth cohorts from 2012 to 2020.
Wang J; Wu QS; Lu J; Ni YH; Zhou F
Vaccine; 2021 Oct; 39(42):6189-6194. PubMed ID: 34538698
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia.
Sundaram N; Chen C; Yoong J; Luvsan ME; Fox K; Sarankhuu A; La Vincente S; Jit M
Vaccine; 2017 Feb; 35(7):1055-1063. PubMed ID: 28109706
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of 13-valent pneumococcal conjugate vaccine on all-cause pneumonia in children under 5 years in Shanghai, China: An observational study.
Tian J; Zheng B; Yang L; Guan Y; Xu C; Wang W
Vaccine; 2023 Sep; 41(41):5979-5986. PubMed ID: 37620204
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.
Earnshaw SR; McDade CL; Zanotti G; Farkouh RA; Strutton D
BMC Infect Dis; 2012 Apr; 12():101. PubMed ID: 22530841
[TBL] [Abstract][Full Text] [Related]
15. Dose-specific Effectiveness of 7- and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-serotype Streptococcus pneumoniae Colonization in Children.
Lewnard JA; Givon-Lavi N; Dagan R
Clin Infect Dis; 2020 Nov; 71(8):e289-e300. PubMed ID: 31784753
[TBL] [Abstract][Full Text] [Related]
16. Modeling Possible Inclusion of Pneumococcal Conjugate Vaccine into the National Immunization Program for Infants in India.
Ghia C; Wasserman M; Fletcher M; Farkouh R; Rambhad G
Value Health Reg Issues; 2018 May; 15():99-105. PubMed ID: 29655052
[TBL] [Abstract][Full Text] [Related]
17. Modeling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico.
Wasserman M; Palacios MG; Grajales AG; Baez/Revueltas FB; Wilson M; McDade C; Farkouh R
Hum Vaccin Immunother; 2019; 15(3):560-569. PubMed ID: 30156978
[TBL] [Abstract][Full Text] [Related]
18. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage Rates of Streptococcus pneumoniae in a Rural Community in the Dominican Republic.
Dunn MG; Lessa FC; Sánchez J; Cordero R; Feris-Iglesias J; Cedano D; Carvalho MDG; Fernández J; Feemster KA
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S237-S247. PubMed ID: 34469551
[TBL] [Abstract][Full Text] [Related]
19. [Dose-response relationship between age and
Li T; Deng WJ; Zhang JF; Li PY; Zhou JL; Yao ZJ; Ye XH
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Oct; 25(10):1059-1065. PubMed ID: 37905764
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013.
Sibak M; Moussa I; El-Tantawy N; Badr S; Chaudhri I; Allam E; Baxter L; Abo Freikha S; Hoestlandt C; Lara C; Hajjeh R; Munier A
Vaccine; 2015 May; 33 Suppl 1():A182-91. PubMed ID: 25919159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
